EXOZ
NASDAQ
Biotechnology
$8.03
USD
+$0.63 (+8.51%)
Last close
Market Cap:
$67.13M
Volume:
8.5K
Previous Close
$7.40
Day Range
$7.21 - $8.03
52 Week Range
$6.33 - $18.40
Average Volume (10 Days)
10K
P/E Ratio
0.00
Dividend Yield
0.00%
eXoZymes, Inc. is a development stage synthetic biochemical company. The company is headquartered in Monrovia California, California and currently employs 32 full-time employees. The company went IPO on 2024-11-13. The firm has developed a platform that offers the tools and insight to control and optimize nature’s own biological processes, enabling their partners to replace traditional chemical production methods with a new sustainable and non-polluting alternative. The Exozymes are advanced enzymes engineered using AI to thrive in a bioreactor outside of living cells.
CEO
Mr. Michael Heltzen
Headquaters
Monrovia California, CALIFORNIA, US
Founded
2024
Employees
32
SERA
Sera Prognostics Inc
$1.80
0.0%
ELTX
Elicio Therapeutics Inc
$4.00
+6.7%
MCRB
Seres Therapeutics Inc
$7.08
+3.4%